SHC
Sotera Health Company
NasdaqGSUSDEQUITY
DELAYED
Last price
19.57
▲ 0.35 (1.82%)
MARKET · —
Price
Open
19.29
Prev close
19.22
Day high
19.63
Day low
19.04
Volume
2.28M
Market cap
—
P/E (TTM)
—
52W range
13.09 – 19.85
Trailing performance
Returnvs SPY
1W
+3.60%
+5.0%
1M
+11.89%
+8.2%
3M
+24.57%
+21.5%
6M
+11.89%
+0.8%
YTD
+10.94%
-1.3%
1Y
+20.06%
+0.1%
3Y
+20.73%
-53.4%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
19.00
+3.01% from price
SMA 20
18.50
+5.76% from price
SMA 50
17.74
+10.30% from price
SMA 100
16.64
+17.58% from price
SMA 200
16.65
+17.53% from price
EMA 12
18.88
+3.66% from price
EMA 26
18.43
+6.16% from price
EMA 50
17.84
+9.70% from price
RSI (14)
68.3
Neutral
MACD (12,26,9)
0.44
Hist 0.04
ATR (14)
0.55
2.79% of price
Realised vol 30D
26.4%
Annualised
Bollinger upper
19.77
20, 2σ
Bollinger lower
17.23
20, 2σ
50 / 200 cross
Golden
17.74 vs 16.65
Trend bias
Above 200
+17.53%
Risk profile
Beta vs SPY
1.03
More volatile than market
Correlation to SPY
0.45
Loosely linked
Realised vol 30D
26.4%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-32.1%
Peak to trough
Max drawdown 5Y
-78.2%
Peak to trough
ATR 14
0.55
2.79% of price
Beta (reported)
—
5Y monthly, from filing
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Headlines
Research Tools & Consumables Stocks Q2 Recap: Benchmarking Sotera Health Company (NASDAQ:SHC)
StockStory · 3d ago
Sotera Health Company (SHC): Buy, Sell, or Hold Post Q2 Earnings?
StockStory · 6d ago
Sotera Health Company’s Q2 Earnings Call: Our Top 5 Analyst Questions
StockStory · 7d ago
Sotera Health (SHC) Q2 2026 Earnings Call Transcript
Motley Fool · 9d ago
3 Healthcare Stocks with Open Questions
StockStory · 10d ago
Sotera Health Company (SHC) Reported Positive Results Amid Litigation Wins
Insider Monkey · 12d ago
SHC Q2 Deep Dive: Broad-Based Growth, Leadership Transition, and Strategic Investments Shape Outlook
StockStory · 12d ago
Sotera Health (SHC) Is Up 5.9% After Q2 Earnings Beat And Guidance Hike What’s Changed
Simply Wall St. · 15d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.